The Chemours Company
CC
$14.12
$0.130.93%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -4.85% | -3.38% | -8.06% | -10.27% | -10.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.85% | -3.38% | -8.06% | -10.27% | -10.54% |
| Cost of Revenue | -2.93% | -1.75% | -4.40% | -7.87% | -7.82% |
| Gross Profit | -11.87% | -9.58% | -20.68% | -18.35% | -19.23% |
| SG&A Expenses | 4.15% | -13.39% | -9.78% | -13.21% | -17.87% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.11% | -3.08% | -5.05% | -8.40% | -9.00% |
| Operating Income | -29.08% | -6.53% | -33.18% | -25.97% | -22.14% |
| Income Before Tax | 140.51% | 115.82% | 410.00% | -166.56% | -142.65% |
| Income Tax Expenses | 150.62% | -- | -143.10% | -164.83% | -149.69% |
| Earnings from Continuing Operations | 137.02% | 125.00% | 234.09% | -167.08% | -140.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 136.71% | 124.37% | 231.82% | -167.48% | -141.00% |
| EBIT | -29.08% | -6.53% | -33.18% | -25.97% | -22.14% |
| EBITDA | -20.09% | -5.31% | -23.61% | -17.93% | -14.73% |
| EPS Basic | 136.73% | 124.41% | 219.42% | -170.09% | -143.56% |
| Normalized Basic EPS | -49.11% | -26.52% | -59.29% | -47.38% | -36.02% |
| EPS Diluted | 134.74% | 123.01% | 208.93% | -172.15% | -145.23% |
| Normalized Diluted EPS | -48.90% | -26.04% | -59.04% | -46.58% | -35.13% |
| Average Basic Shares Outstanding | 0.40% | 0.05% | -1.25% | -2.45% | -4.17% |
| Average Diluted Shares Outstanding | 0.06% | -0.29% | -1.46% | -3.31% | -5.03% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 3.71% | 5.10% | 1.74% | -2.46% | -3.36% |
